Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Proteomics Group Using Protein Forest's Separation Tech, Software

NEW YORK (GenomeWeb News) - Protein Forest said today that it has shipped its protein separation technology and software to the proteomics group at Thermo Fisher Scientific.
 
Thermo scientists will use Protein Forest’s digital ProteomeChip separation system, which fractionates and concentrates proteins or peptides by isoelectric focusing, as well as its Mass Spec Results and Analysis Tool, or MSRAT, software, which was designed to help researchers interpret the results of experiments that use the ProteomeChip technology.
 
Researchers at Thermo Fisher will use the ProteomeChip system with Orbitrap and triple quadrupole mass spectrometer systems “on a variety of challenging proteomics research projects,” Protein Forest said.
 
Andreas Hühmer, director of proteomics at Thermo Fisher, said in a statement that the ProteomeChip system “could be a superior alternative to 2D gels, SDS-PAGE, and HPLC-based sample preparation methodologies in many workflows, and improve the quality and quantity of protein research results.”
 
Financial terms of the agreement were not provided.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.